| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/11/2008 | CA2588361A1 Methods of treatment and prevention of neurodegenerative diseases and disorders |
| 11/10/2008 | CA2588491A1 Composition and method for increasing the metabolism of free fatty acids and facilitating a favorable blood lipid profile |
| 11/10/2008 | CA2588436A1 Composition and method for inducing lipolysis and increasing the metabolism of free fatty acids |
| 11/09/2008 | CA2587185A1 Methods and compositions for the diagnosis and treatment of ewing's sarcoma |
| 11/07/2008 | CA2588942A1 The original sheridan cecil spicer scalpe loosers and scalpe healing hair restoration solution and healthy haire management system |
| 11/06/2008 | WO2008134761A2 Modification of biological targeting groups for the treatment of cancer |
| 11/06/2008 | WO2008134727A1 Methods and compositions for treatment of reperfusion injury and other cardiac conditions |
| 11/06/2008 | WO2008134693A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 11/06/2008 | WO2008134690A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 11/06/2008 | WO2008134668A2 Heat-labile prodrugs |
| 11/06/2008 | WO2008134646A2 Rna interference suppression of neurodegenerative diseases and methods of use thereof |
| 11/06/2008 | WO2008134645A1 Compositions and approaches for increasing diet induced thermogenesis, inducing weight loss and maintaining muscles mass and strength |
| 11/06/2008 | WO2008134644A1 High viscosity macromolecular compositions for treating ocular conditions |
| 11/06/2008 | WO2008134630A1 Dexrazoxane compounds for cardioprotection |
| 11/06/2008 | WO2008134628A2 Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones |
| 11/06/2008 | WO2008134618A2 Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders |
| 11/06/2008 | WO2008134616A2 Use of intravitreal viscosurgical injection agents for repair of rhegmatogenous (bullous) retinal detachment |
| 11/06/2008 | WO2008134602A1 Levosimendan dosage regimen |
| 11/06/2008 | WO2008134601A1 Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin |
| 11/06/2008 | WO2008134600A1 Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use |
| 11/06/2008 | WO2008134557A2 Solid dosage forms |
| 11/06/2008 | WO2008134553A1 Methods of using bicyclic compounds in treating sodium channel-mediated diseases |
| 11/06/2008 | WO2008134547A1 Methods of using hydroxycyclohexane and hydroxypiperidine compounds in treating sodium channel-mediated diseases or conditions |
| 11/06/2008 | WO2008134540A1 Compositions and methods for transmucosal delivery of domperidone |
| 11/06/2008 | WO2008134525A1 Deuterium labelled ketamine |
| 11/06/2008 | WO2008134523A1 Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease |
| 11/06/2008 | WO2008134518A2 Methods and compounds for vitamin d therapy |
| 11/06/2008 | WO2008134513A2 Copper lowering treatment of autoimmune diseases |
| 11/06/2008 | WO2008134512A1 Oral controlled release compositions comprising vitamin d compound and waxy carrier |
| 11/06/2008 | WO2008134487A1 Macrophage transfection method |
| 11/06/2008 | WO2008134480A1 Non-basic melanin concentrating hormone receptor-1 antagonists |
| 11/06/2008 | WO2008134474A2 Compositions and methods including cell death inducers and procaspase activation |
| 11/06/2008 | WO2008134468A1 Bioactive and biocompatible polyurethane-butanediol-glycosaminoglycan salt copolymers |
| 11/06/2008 | WO2008134395A1 Aza-peptide macrocyclic hepatitis c serine protease inhibitors |
| 11/06/2008 | WO2008134354A1 TNF-α PRODUCTION INHIBITOR |
| 11/06/2008 | WO2008134300A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 11/06/2008 | WO2008134265A2 Iminosugar for treatment of tumors |
| 11/06/2008 | WO2008134228A1 Benzoxazole compounds |
| 11/06/2008 | WO2008134221A1 Pharmaceutical use of substituted amides |
| 11/06/2008 | WO2008134088A1 Hydroxy sulfonate of quinone compounds and their uses |
| 11/06/2008 | WO2008134082A1 Erythropoietin complementation or replacement |
| 11/06/2008 | WO2008134071A1 Multimodal abuse resistant extended release formulations |
| 11/06/2008 | WO2008134048A2 Methods for synthesizing and purifying aminoalkyl tetracycline compounds |
| 11/06/2008 | WO2008134036A1 ALPHA-SUBSTITUTED ARYLMETHYL PIPERAZINE PYRAZOLO[1,5-α]PYRIMIDINE AMIDE DERIVATIVES |
| 11/06/2008 | WO2008134035A1 Alpha-unsubstituted arylmethyl piperazine pyrazolo[1,5-a] pyrimidine amide derivatives |
| 11/06/2008 | WO2008134033A1 Dna polymerase inhibitors composition and methods |
| 11/06/2008 | WO2008133975A1 Multi-ring compounds and uses thereof |
| 11/06/2008 | WO2008133973A1 Therapeutic agents useful for treating pain |
| 11/06/2008 | WO2008133955A1 6-phenylpyrimidinones as pim modulators |
| 11/06/2008 | WO2008133954A1 Amido-amine dendrimer compositions |
| 11/06/2008 | WO2008133952A2 Transmucosal treatment with fentanyl in patients with mucositis |
| 11/06/2008 | WO2008133949A1 Analogues of cilostazol |
| 11/06/2008 | WO2008133937A2 Compositions of tolperisone |
| 11/06/2008 | WO2008133933A1 Methods, systems, and compositions for treating or ameliorating the effects of a non-congenital hypertonia |
| 11/06/2008 | WO2008133901A1 Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins |
| 11/06/2008 | WO2008133900A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| 11/06/2008 | WO2008133896A2 Dual-acting antihypertensive agents |
| 11/06/2008 | WO2008133884A2 Methods and compositions for the treatment of neurodegenerative disorders |
| 11/06/2008 | WO2008133877A1 Inhibitors for steroid response elements and related methods |
| 11/06/2008 | WO2008133867A1 2-substituted indole derivatives as calcium channel blockers |
| 11/06/2008 | WO2008133866A1 Polymorph of dihydropyrazolopyrimidinone derivative as weel kinase.inhibitor |
| 11/06/2008 | WO2008133801A1 Ceramide derivatives as modulators of immunity and autoimmunity |
| 11/06/2008 | WO2008133789A2 Methods and compositions for targeting afap |
| 11/06/2008 | WO2008133772A1 Method for modulating activity of t lymphocytes |
| 11/06/2008 | WO2008133766A1 Blocking the migration or metastasis of cancer cells by affecting adhesion proteins and the uses of new compounds thereof |
| 11/06/2008 | WO2008133753A2 Anti-viral compounds |
| 11/06/2008 | WO2008133734A2 Method and compositions for treating hiv infections |
| 11/06/2008 | WO2008133704A2 Antimicrobial and antiviral compounds and methods for their use |
| 11/06/2008 | WO2008133669A2 Viral inhibitors |
| 11/06/2008 | WO2008133664A2 Carboranylporphyrins and uses thereof |
| 11/06/2008 | WO2008133635A1 Novel soluble 1,4 benzodiazepine compounds and stable salts thereof |
| 11/06/2008 | WO2008133595A1 Compositions and methods for stimulating an immune response in-vivo and in-vitro |
| 11/06/2008 | WO2008133537A1 Pharmaceutical composition exhibiting improved stability comprising ace inhibitor or pharmaceutically acceptable salt thereof and method for manufacturing thereof |
| 11/06/2008 | WO2008133330A1 Stable solid preparation comprising 4,5-epoxymorphinan derivative |
| 11/06/2008 | WO2008133297A1 Therapeutic or prophylactic agent for dyskinesia |
| 11/06/2008 | WO2008133288A1 Tricyclic aryl compounds |
| 11/06/2008 | WO2008133274A1 Aminodihydrothiazine derivatives substituted with cyclic groups |
| 11/06/2008 | WO2008133273A1 Pharmaceutical composition for treatment of alzheimer's disease |
| 11/06/2008 | WO2008133272A1 Medicated patch |
| 11/06/2008 | WO2008133208A1 Method for enhancing immune response with peptide |
| 11/06/2008 | WO2008133198A1 Neurite formation promoter |
| 11/06/2008 | WO2008133192A1 Fused imidazole compound and use thereof |
| 11/06/2008 | WO2008133155A1 Bicyclic heterocyclic compound |
| 11/06/2008 | WO2008133132A1 Method for improvement in activities of reactive oxygen species-scavenging enzymes |
| 11/06/2008 | WO2008133129A1 Therapeutic agent for glaucoma comprising adenosine a2a receptor agonist as active ingredient |
| 11/06/2008 | WO2008133128A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 11/06/2008 | WO2008133127A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 11/06/2008 | WO2008133102A1 Novel base for dry solid dispersion, solid dispersion containing the base, and composition containing the dispersion |
| 11/06/2008 | WO2008133036A1 Method for screening of therapeutic agent for renal tubular dysfunction |
| 11/06/2008 | WO2008133021A1 COMPOSITION FOR AMELIORATING OPTIC NERVE DISORDER COMPRISING PROSTAGLANDIN F2α COMPOUND AS ACTIVE INGREDIENT |
| 11/06/2008 | WO2008132950A1 External preparation for skin and external preparation for lips |
| 11/06/2008 | WO2008132846A1 Tricyclic heteroaryl compound |
| 11/06/2008 | WO2008132756A1 Stable pharmaceutical compositions of ramipril |
| 11/06/2008 | WO2008132738A2 Anticancerous polymeric agents |
| 11/06/2008 | WO2008132710A2 Pharmaceutical nimodipine compositions |
| 11/06/2008 | WO2008132682A2 Improved vitamin d content uniformity in pharmaceutical dosage forms |
| 11/06/2008 | WO2008132611A2 Interactive variable pathleingth device |
| 11/06/2008 | WO2008132608A2 Combined use of egf pathway inhibitors and differentiation promoting compounds |
| 11/06/2008 | WO2008132600A2 Trpv1 antagonists and uses thereof |
| 11/06/2008 | WO2008132589A1 Combinations comprising pregabalin |